All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Liraglutide 1.8mg: Switching To

How to switch to liraglutide 1.8mg. Covers stepping up from 1.2mg, switching from Victoza to Saxenda at this dose, what the transition feels like, and...

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Liraglutide 1.8mg: Switching To custom 2026 header image for GLP-1 Weight Loss
Custom header image for Liraglutide 1.8mg: Switching To, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Liraglutide 1.8mg: Switching To

How to switch to liraglutide 1.8mg. Covers stepping up from 1.2mg, switching from Victoza to Saxenda at this dose, what the transition feels like, and...

Short answer

How to switch to liraglutide 1.8mg. Covers stepping up from 1.2mg, switching from Victoza to Saxenda at this dose, what the transition feels like, and...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

How to switch to liraglutide 1.8mg. Covers stepping up from 1.2mg, switching from Victoza to Saxenda at this dose, what the transition feels like, and pen supply considerations.

Switching to liraglutide 1.8mg is the third dose increase in the titration, moving up from 1.2mg after at least one week at that level. The increase is made by dialing the same pen to 1.8mg. This 50 percent increase is the largest remaining proportional step in the titration, making it the most significant transition you'll feel. Most patients handle it smoothly, but this is the dose where GI side effects are most likely to appear during the dose-escalation process.

Standard Titration: 1.2mg to 1.8mg

The move from 1.2mg to 1.8mg follows the standard weekly titration schedule. After seven days at 1.2mg, dial your pen to the 1.8mg mark on day 15 of treatment. liraglutide titration schedule

Readiness indicators before switching:

  • At least 7 days completed at 1.2mg
  • GI symptoms from the 1.2mg transition have resolved
  • You're eating regular meals without distress
  • No concerning symptoms that require evaluation
  • Adequate pen supply for the higher dose (pens run out faster at 1.8mg)

If these criteria are met, proceed with the increase. If GI symptoms from 1.2mg are still present, consider an extra week before moving up. liraglutide 1.2mg how long to stay on

Why 1.8mg Is the important Step

The proportional increases throughout the titration show why 1.8mg is significant:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Liraglutide 1.8mg: Switching To
Transition Proportional Increase
0.6mg to 1.2mg 100% (doubled)
1.2mg to 1.8mg 50%
1.8mg to 2.4mg 33%
2.4mg to 3.0mg 25%

While the 0.6mg-to-1.2mg step is technically larger in percentage terms, the 1.2mg-to-1.8mg step brings you into truly therapeutic territory for the first time. The absolute amount of GLP-1 receptor activation at 1.8mg produces noticeable physiological effects that many patients did not feel at lower doses.

What the Switch Feels Like

Patient experiences during the transition from 1.2mg to 1.8mg:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Appetite shift: The clearest change most patients notice. Hunger between meals diminishes noticeably. The drive to eat outside of planned meals weakens. This is the dose where many patients first describe feeling "in control" of their eating.
  • GI adjustment: Approximately 20 to 30 percent of patients experience some nausea during the first 2 to 3 days. This is the most GI-eventful transition in the titration for most patients. It's usually manageable with diet adjustments.
  • Satiety signals: Full feeling arrives earlier and lasts longer. Patients commonly report that they stop eating mid-meal because they genuinely feel satisfied, not because they're forcing themselves to stop.
  • Mental clarity about food: The constant background hum of food thoughts, cravings, and planning begins to quiet. For patients who have struggled with food preoccupation, this is often the most valued change.

Liraglutide 1.8mg what to expect

Switching from Victoza 1.8mg to Saxenda

Patients already on Victoza at the maximum 1.8mg dose who want to switch to Saxenda for weight management have a straightforward path:

  • You're already at 1.8mg, so no additional titration is needed at this level
  • Your prescriber writes a Saxenda prescription starting at 1.8mg
  • From there, increase to 2.4mg after one week, then 3.0mg the following week
  • You reach the full Saxenda dose in just two additional weeks rather than five

This accelerated timeline is possible because your body is already fully adapted to liraglutide 1.8mg. compounded formulations of the active ingredient is in both products, so there's no cross-medication adjustment needed.

Insurance note: Even though the same drug is used, Victoza and Saxenda are different products with different coverage rules. Verify your plan's coverage for the Saxenda brand before making the switch. Contact provider for current pricing

Pen Supply Management at 1.8mg

At 1.8mg daily, each Saxenda pen (18mg total) lasts approximately 10 days. This is a notable change from the 0.6mg phase where a single pen lasted 30 days:

  • A 5-pen box lasts approximately 50 days at 1.8mg
  • As you continue titrating to 3.0mg, pens will last only about 6 days each
  • Order refills proactively. Most pharmacies require 3 to 5 business days for specialty medications
  • Running out of medication during the titration phase is particularly disruptive because it may require restarting from a lower dose

Contact provider for current pricing

Frequently Asked Questions

Can I skip 1.8mg and go directly from 1.2mg to 2.4mg?
This isn't recommended. The jump from 1.2mg to 2.4mg doubles the dose and significantly increases nausea and vomiting risk. The one-week stay at 1.8mg helps your body adapt to the intermediate level. Follow the prescribed titration.
I felt nothing at 1.2mg. Will 1.8mg be different?
Very likely. The 50 percent dose increase brings most patients into the perceptible range for appetite suppression. The 1.2mg dose is at the low end of therapeutic activity. At 1.8mg, the effect crosses a threshold that most patients can feel.
Should I adjust my meal plan when switching to 1.8mg?
Minor adjustments help. Slightly smaller portions, protein at every meal, and avoiding heavy or greasy foods for the first 2 to 3 days smooth the transition. You don't need a complete diet overhaul at this stage.
What if 1.8mg gives me too many side effects?
Options include staying at 1.8mg for an additional week to allow further adaptation, stepping back to 1.2mg for a week and then trying 1.8mg again, or discussing anti-nausea medication with your prescriber. Don't discontinue the medication without consulting your prescriber. liraglutide 1.8mg side effects
Is 1.8mg a good maintenance dose for weight loss?
For most patients, 1.8mg is sub-optimal for weight management. The full 3.0mg dose produces approximately twice the weight loss. But some patients achieve acceptable results at 1.8mg and prefer it for tolerability reasons. Discuss with your prescriber whether 1.8mg meets your goals. liraglutide 1.8mg results timeline

This article is for informational purposes only and doesn't constitute medical advice. Follow your prescriber's titration recommendations for the safest and most effective transition.

Contact provider for current pricing Contact provider for current pricing

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Retatrutide evidence source
Official source
Saxenda evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Liraglutide 1.8mg: Switching To, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not a claim that every study applies to every patient.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Liraglutide 1.8mg: Switching To research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

How to switch to liraglutide 1.8mg. Covers stepping up from 1.2mg, switching from Victoza to Saxenda at this dose, what the transition feels like, and pen supply considerations. "Liraglutide 1.8mg: Switching To" is most useful when you treat it as decision prep, not a shortcut. The page is built around patient education and clinical context, with the highest-value checks sitting around dosing. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the answer affects treatment, cost, pharmacy choice, or dosing, bring the specifics to a licensed clinician before acting.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Liraglutide 1.8mg

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, liraglutide so the article stays close to the question behind "Liraglutide 1.8mg".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Liraglutide 1.8mg from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Liraglutide 1.8mg custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Liraglutide 1.8mg, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Liraglutide 1.8mg, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $299/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.